"Through individualized and patient-focused treatments, our complete and comprehensive neurological care is dedicated to advancing each patient’s neurological wellbeing. Our team of specialists is able to provide these advanced services for patients dealing with brain tumors, concussions, epilepsy and seizure disorders, headaches, migraines, neurodegenerative diseases, Alzheimer’s disease, Parkinson’s disease, spine injury, stroke and traumatic brain injury."

During the past decade, Mission Neuroscience Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Mission Neuroscience Institute" are "Cervical Disc Disease" (2 trials). Many other conditions were trialed in "Mission Neuroscience Institute" in a lesser frequency.

Most popular intervention types in "Mission Neuroscience Institute" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "BAGUERA®C Cervical Disc Prosthesis" (2 trials), "Mobi-C Cervical Disc" (1 trials) and "Mobi-C® Cervical Disc" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mission Neuroscience Institute" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Mission Neuroscience Institute". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Mission Neuroscience Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mission Neuroscience Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".